News | Robotic Systems | December 06, 2017

Robocath Receives $1.5 Million in Capital for Advancement of R-One Robotic System

New funding aims to increase resources available for marketing and development of the next generation of robotics dedicated to the treatment of strokes

Robocath Receives $1.5 Million in Capital for Advancement of R-One Robotic System

December 6, 2017 — French company Robocath, which designs and develops robotic solutions for the treatment of vascular diseases, announced an increase in capital of €1.7 million ($2 million). This is partly thanks to a €1.25 million ($1.5 million) contribution from Crédit Agricole Innovations et Territoires (CAIT), a fund dedicated to technological innovation in France, managed by Supernova Invest. Cardio Participation, a holding company bringing together several business angels, also invested €450,000 ($530,000). This latest financial contribution supplements the €4.7 million ($5.6 million) raised by Robocath in a previous round of fundraising in May.

Robocath’s R-One technology optimizes and increases the safety of robotic-assisted coronary angioplasty. The technology allows the surgeon to operate with extreme precision and in optimal conditions. Intuitive to use, R-One allows the surgeon to operate from a seated position and to use a portable protective screen to guard against X-rays. This first robotic platform will be marketed in Europe and the Middle East in 2018.

Thanks to this funding, Robocath will also begin researching and developing the next generation of robotic solutions. The new platform will be used to treat neurovascular diseases such as strokes, the second leading cause of death in the world after hearts attacks. The new solution will also aim to improve care for these conditions.

For more information: www.robocath.com

Related Content

News | Cath Lab
April 25, 2022 – NewYork-Presbyterian Hudson Valley Hospital celebrated the launch of its interventional cardiology ...
Home April 25, 2022
Home
News | Cath Lab
April 18, 2022 – Royal Philips and Oulu University Hospital (Finland) have announced a strategic 10-year partnership ...
Home April 18, 2022
Home
News | Cath Lab
February 16, 2022 – Fremont Bank Foundation recently donated $750,000 to its community partner, St. Rose Hospital ...
Home February 16, 2022
Home
News | Cath Lab
February 14, 2022 — A collaborative effort between The Valley Heart and Vascular Institute’s cardiology team ...
Home February 14, 2022
Home
Sponsored Content | Videos | Cath Lab

Advancements in analytics and data visualizations are helping to streamline operations and improve productivity at cath ...

Home January 13, 2022
Home
News | Cath Lab

January 4, 2022 — The U.S. Food and Drug Administration (FDA) has authorized marketing of the first laser-based device ...

Home January 04, 2022
Home
News | Cath Lab

December 14, 2021 — RSIP Vision, a medical imaging company applying advanced artificial intelligence (AI) and computer ...

Home December 14, 2021
Home
Feature | Cath Lab

November 15, 2021 — RealView Imaging Ltd. recently received FDA 510(k) clearance for its Holoscope-i holographic system ...

Home November 15, 2021
Home
News | Cath Lab

November 10, 2021 — Shockwave Medical a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely ...

Home November 10, 2021
Home
News | Cath Lab

November 10, 2021 — Philips Healthcare announced North American availability of new innovations in its portfolio of ...

Home November 10, 2021
Home
Subscribe Now